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The Chinese medical device market: 
Market drivers and investment prospects 
 
 
 
Abstract 
The economy in China has experienced rapid growth and been remarkably successful ever 
since the reforming and opening-up policy. Like ChiŶa’s ecoŶoŵǇ, the Chinese medical device 
market is developing rapidly; this paper identifies important parameters controlling this 
market. Regression analysis shows that the number of hospital visits, aging population and 
the number of hospitals have a positive relationship with medical device revenues. Therefore, 
they are the main drivers of the Chinese medical device market. Disease profile is another 
important market driver. Analysis of the main market drivers, illustrates that the Chinese 
medical device market offers significant investment opportunities.  
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Introduction 
The global medical device market is highly centralized.1 The market share of the developed 
countries accounted for more than 80% of the global medical device market share (US: 42.4%, 
Europe: 33%, Japan: 11%) in 2011.2 With superior know-how in technology and/or 
management, international companies are typically larger than domestic companies and have 
a competitive advantage due to the economies of scale.3 According to Charles Hill and Vernon’s 
product life cycle theory, the developed countries will export their production and technology 
from their relatively saturated market to the developing countries due to the market pressures 
and other competition in their established markets.4-6 Despite China only accounting for 3% of 
the global medical device market share,2 this study shows that the developing countries’ 
medical device markets are experiencing rapid growth, especially in China. Increasing medical 
expenditure, rising healthcare consumption and health awareness improvements are all 
possible factors in promoting the development of the Chinese medical device market. The 
Chinese government’s healthcare reform has injected additional “power” into the development 
of the medical device market. In fact, by the end of 2011, the Chinese medical device industry 
output value was 688.42 billion yuan, total percentage of GDP is 1.40%. Figure 1 shows the 
Chinese medical device industry output value and its total percentage of GDP, its value 
continues to climb from 2001 to 2011. In 2011, the percentage of medical device industry 
output value accounted for 1.40% of Chinese GDP. Although the output value of the medical 
device industry is currently a limited proportion of the national economy, Figure 1 shows a 
rising trend year by year except 2008. 
 
Figure ϭ ChiŶa’s ŵedical device industrial output value and its total (% of GDP). 
Source: NatioŶal Bureau of Statistics of ChiŶaϳ, ϴ 
 
China’s high-end medical device market is dependent upon imports and dominated by foreign 
companies’ products, especially for the diagnosis and treatment devices. Table 1 shows the 
Chinese medical market trade statistics according to the China Chamber of Commerce for 
Import & Export of Medicines & Health Products (CCCMHPIE) in 2010. The overall trend of 
the Chinese healthcare market shows that export value is higher than import value; hence the 
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export value of the pharmaceutical and medical device industry is higher than the import value. 
However, only the import value of medical diagnosis and treatment devices is higher than the 
export value, which took a 29.05% share of total import volume in China. By comparison, 
medical dressings, disposable products, health protection and recovery products, dental 
equipment and materials, total only 6.8% of import volume, which is only one-quarter of the 
import volume of the medical diagnosis and treatment sector.  
 
Table 1 ChiŶa’s iŵport aŶd eǆport structure of ŵedicines and health products, 2010. 
(Unit: million USD) 
Trade name Export 
Value 
 
Export value 
growth rate 
annually (%) 
Share in 
total 
export 
volume 
(%) 
Import 
Value 
 
Import value 
growth rate 
annually (%) 
Share in 
total 
import 
volume 
(%) 
Total 39,733.10 24.87 100 20,464.36 23.98 100 
1.Traditional Chinese 
Medicine 
1,944.47 22.78 4.89 687.95 22.61 3.36 
2.Pharmaceuticals 23,930.02 28.17 60.23 12,440.84 20.53 60.79 
3.Medical Devices 13,858.61 19.83 34.88 7,335.57 30.45 35.85 
3.1 Medical 
dressings 
4,687.51 11.95 11.8 207.77 25.63 1.02 
3.2 Disposable 
products 
1,922.27 15.42 4.84 880.76 27.73 4.3 
3.3 Medical 
diagnosis and 
treatment 
4,543.60 25.56 11.44 5,944.73 30.34 29.05 
3.4 Health 
protection 
and recovery 
products 
2,416.41 30.87 6.08 149.37 83.83 0.73 
3.5 Dental 
equipment 
and materials 
288.82 16.51 0.73 152.94 21.37 0.75 
Source: CCCMHPIE, 20119 
 
More specifically, Table 2 illustrates the trade statistics for medical devices in China in 2010. 
The total export value of medical devices reached USD 13.86 billion in 2010, while the total 
import value reached USD 7.3 billion. North America and Asia are the main export target areas 
for China, which accounted for 29.23% and 33.7% of the total export volume; the U.S. and 
Japan are the main export target countries, which absorbed 27.91% and 10.39% of the total 
export volume respectively. Europe and North America are the main exporters to China, which 
accounted for 39.01% and 31.41% of the total import volume. Germany and the U.S. are the 
main importing countries, which provide 17.34% and 30.71% of the total import volume. 
 
Table 2 ChiŶa’s iŵport aŶd eǆport ŵarkets of ŵedical devices iŶ ϮϬϭϬ.   (Unit: million USD)                                                      
Country Export Value 
 
Export 
value 
growth 
rate 
annually 
(%) 
Share in 
total 
export 
volume 
(%) 
Import Value 
 
Import value 
growth rate 
annually (%) 
Share in 
total 
import 
volume 
(%) 
Total (All countries) 13,858.61 19.83 100 7,335.57 30.45 100 
Asia 4,669.96 12.87 33.7 1,938.77 29.28 26.43 
Europe 3,631.06 18.53 26.2 2,861.38 34.38 39.01 
North America 4,051.03 24.48 29.23 2,303.79 25.81 31.41 
       
1. U.S. 3,867.61 24.72 27.91 2,252.64 26.48 30.71 
2. Germany 778.06 14.72 5.61 1,271.74 35.43 17.34 
3. Japan 1,440.07 -13.5 10.39 1,113.90 26.99 15.18 
Source: CCCMHPIE, 201110 
For the Chinese medical device market, with growth from many sources of demand, medical 
diagnosis and treatment devices still have a great growth potential. China now has a fee-for-
service healthcare system financed largely by payments from patients, employers and health 
insurance companies.11 However, many patients especially high income people are willing to 
pay more money by themselves on their treatment, especially for cancers, heart disease, 
cerebrovascular disease, etc., which needs to use high-tech medical diagnosis and treatment 
devices or high-grade drugs, which is not affordable for low income people. For example, the 
average fees for CT whole body scan is nearly 2500 yuan (about USD 400) in China, this is 
not a small expenditure for low income people; they always choose the most economic ways 
to treat their diseases. However, China’s health institutions especially the Tier-3 hospitalsa have 
a strong demand for high-end diagnostic devices due to the rising number of visits and 
inpatients, changed disease profiles, etc.. 
Data 
The improvement of medical and health services has greatly increased the market capacity for 
the Chinese medical device industry. The important medical device industry drivers are (1) 
demographics, the percentage of the global and Chinese population above 65 years old is 
growing. (2) unmet clinical needs, the trend of using new medical devices or products to 
address diseases or medical needs that previously were simply not treated is increasing. (3) 
procedure penetration, there is a tendency among doctors to use more medical products and 
procedures. (4) pricing, positive pricing trends have generally been favourable in the medical 
device industry. Medical products are not selected on the basis of price. (5) geographic reach, 
the market potential for the highly-populous less-developed countries (including China) is very 
compelling.12 Studying the market growth drivers of the Chinese medical device market 
provides information for effective investment in China. 
Data for medical device industry revenues from 2000 to 2012 was collected from the China 
Statistics Yearbook on High Technology Industry.13 Other data such as the number of hospital 
visits and number of hospitals were collected from the China Health Statistical Yearbook.14 
                                                          
a
 There are three levels of Chinese hospitals: Tier-3 Hospitals (6%) tend to be the best and highest level (first class) 
hospitals, which may offer the most comprehensive medical treatment; complex clinical diagnosis, advanced 
scientific research and R&D abilities, which are provincial and municipal hospitals in big cities; Tier-2 Hospitals 
(34%) are providing comprehensive medical services, basic teaching and research functions, which are municipal 
hospitals in smaller cities as well as district and county hospitals; Tier-1 Hospitals (25%) are grass-roots healthcare 
institutions, providing basic medical services, which are the primary healthcare facilities in small towns; Other 
healthcare institutions account for 35% of total medical institutions. 
Data on 65+ population was collected from the China Statistical Yearbook.15 In this study, 
datasets contain every mainland Chinese province and city except Hong Kong, Macao and 
Taiwan. Data on the number of hospitals does not include other health institutions such as 
Grass-roots Health Care institutions b , Specialized Public Health Institutions c  and other 
healthcare institutions. The detailed data are shown in the Supplement Table A.  
Methods and empirical analysis 
In the real economic environment, one variable is affected by several factors. Multiple 
regression analysis has been selected as the research method in this study. Assume the 
regression equation is: �� = �଴ + �ଵ�ଵ + �ଶ�ଶ + ⋯ + ���� + ��                 ሺͳሻ 
where � is the dependent variable, � are the explanatory variables, � the stochastic disturbance 
term, and � the �th observation.16 Using the data in Supplement Table A, we set:  �=medical 
device revenues, �ଵ=number of hospital visits, �ଶ=65+ population, �ଷ=hospital quantity. From 
Microsoft Excel we obtained the following regression result:  ��̂ = −ͳͲʹ͸͸͸͵.ͺ͵ + ͵͹Ͳ.Ͷ͸�ଵ + ͸ͳͳͻ.Ͳͳ�ଶ + ͵.͹Ͳ�ଷ                           � = ሺ−͹.͸ͻͶ͸ሻ      ሺ͸.ͳ͸ͳ͸ሻ    ሺͳ.ͷ͹ʹʹሻ     ሺͲ.ʹͲͲͺሻ          ሺʹሻ      �ଶ = Ͳ.ͻͻʹͺ     �̅ଶ = Ͳ.ͻͻͲͶ  
where ��̂=estimator of ��, �̅ଶ=adjusted �,  �= � value, used for � test. 
Regression shows that the number of hospital visits, 65+ population and hospital number 
together explain 99% of the variation in medical device revenues. The estimated value of the 
coefficients of the: number of hospital visits, 65+population and hospital number are 370.46, 
6119.01 and 3.70, respectively. The detailed data are shown in the Supplement Table B. 
Hypothesis testing (the � test) assumes �଴: ��=0, (�=1, 2, 3). Regression illustrates that the � of �ଵ̂=6.1616, � of �ଶ̂=1.5722, � of �ଷ̂=0.2008. The � test of significance decision rules is shown 
in the Supplement Table C. If we assume αd=0.05, degrees of freedom (df) = n-4=13-4=9e. 
According to percentage points of the �  distribution (Supplement Table D),  ��/ଶ,��=�଴.଴5/ଶ(9)=2.262. Therefore, �ଵ=6.1616>�଴.଴5/ଶ(9), which is significant, so reject �଴, 
which means that the number of hospital visits has significant impact on medical device 
revenues. �ଶ=1.5722<2.262 and �ଷ=0.2008<2.262, so accept �଴: �ଶ=0 and �଴: �ଷ=0, which are 
insignificant. 
The regression model is based on several assumptions, one of the assumptions is that “There 
is no exact collinearity between the � (explanatory) variables”. Insignificant � values but a high 
overall �ଶ  is one of the signals for multicollinearity.16 After correlation using Excel we 
obtained �ଵଶ=0.9644, �ଵଷ=0.9423, �ଶଷ=0.9831, which means three explanatory variables are 
                                                          
b Grass-roots Health Care institution includes community health centre and station, sub-district health centre, 
village clinic, outpatient department, and, clinic (infirmary) 
c  Specialized Public Health Institution includes Chinese Centre for Disease Control and Prevention (CDC), 
specialized disease prevention and treatment institution, health education centre, maternal and child health centre, 
emergency centre, centre for blood collection & supply, centre for health supervision and centre for family 
planning service.  
d α (0< α<1) is known as the level of significance. 
e n means number of observations 
highly correlated. Thus, we regress �  on �  individually. Detailed data are shown in the 
Supplement Table E. ��̂ = −͸Ͳͻ͹Ͷ͵.͸Ͳ + ͷͷ͵.͵Ͷ�ଵ                                               � = ሺ−ͳ͹.ʹ͵ሻ          ሺʹ͸.Ͷͻሻ       �ଶ = Ͳ.ͻͺ      ሺ͵ሻ    
The regression (equation 3) shows that the number of hospital visits variable is highly 
significant, and ��/ଶ,��=�଴.଴5/ଶ(11)=2.201. �ଵ=26.49>�଴.଴5/ଶ (11), therefore reject �଴. The same 
with equation (2)’s results, which means the number of hospital visits has significant impact 
on medical device revenues.  ��̂ = −ͳ͹ͶͺͲʹͺ.Ͳͷ + ͳͻ͵ͻͳ.͵͸�ଶ                                      � = ሺ−ͳͶ.ʹͲሻ       ሺͳ͸.͹͵ሻ      �ଶ = Ͳ.ͻ͸     ሺͶሻ 
The regression (equation 4) and � test (�ଶ=16.73>�଴.଴5/ଶ (11)=2.201) illustrates that the 65+ 
population variable was statistically insignificant, whereas now it is highly significant.  ��̂ = −ͳͺͻ͹͸ͳͳ.͵ͳ + ͳͳͶ.Ͳʹ�ଷ                                        � = ሺ−ͻ.ͻͺሻ       ሺͳͳ.͸ͳሻ      �ଶ = Ͳ.ͻʹ     ሺͷሻ �ଷ=11.61>�଴.଴5/ଶ (11)=2.201, and regression equation (5) shows that hospital number now has 
a significant impact on medical device revenues, whereas in equation (2) it had no effect on 
medical device revenues. 
According to equation (3), there is a positive linear correlation between the number of hospital 
visits and medical device industry revenues, which means every one million change in the 
number of hospital visits will cause a positive change of 553.34 million yuan (RMB) in medical 
devices revenues. 
The huge population and aging population are one of the factors for the growth of China’s 
pharmaceutical market,17 as well as the medical device market. According to equation (4), the 
regression shows that every one million change in 65+ population will cause a positive change 
of 19391.36 million yuan in medical devices revenues. It is clear that the 65+ population is the 
most important driver of the medical device market. From the year of 1990 to 2010, the Chinese 
population increased from 1.14 billion to 1.341 billion. However, the population growth rate 
declined since 1990.18 Figure 2 shows the trend of Chinese population growth rate from 1980 
to 2010, the detailed data are shown in the Supplement Table F. The total population increased 
slowly, but the population growth rate decreased year by year since 1990 due to the decrease 
in fertility and mortality.19 The reduction in population growth rate speeds up the growth in the 
aging population. An important need of the “aging society” is high quality healthcare, because 
the elderly are experiencing increasing rates of chronic diseases,20 someone in their 80’s is very 
likely to have four or five chronic diseases. Therefore, the medical device market in China is 
set to expand. 
 Figure 2 The growth rate of Chinese population from 1980 to 2010 
Equation (5) illustrates that the number of hospitals has a positive linear correlation with 
medical device revenues.  
Other driving forces such as diseases cannot easily use quantitative method to assess their 
impact. China now belongs to the upper middle income countries;21 of the top ten leading 
causes of death in the middle income countries, seven are chronic disease-related deaths, which 
accounted for 91% of total deaths.22 The higher burden of chronic diseases in low- and middle 
income countries is manifest in China,23 which means these diseases will cost a great deal. 
Although digestive diseases, respiratory diseases, infectious and parasitic diseases are the top 
ten leading causes of death in low- and middle income countries, we need to focus more 
attention on cancers, cardiovascular diseases and cerebrovascular diseases, which account for 
the top three percent of total deaths in China.22 The top three leading causes of death in middle-
income countries are cardiovascular diseases, cerebrovascular diseases and respiratory 
diseases,23-25 there were 2.8 million deaths from cardiovascular diseases in China in 2003.24 
Cancer caused the highest mortality and has maintained the first position among the five 
leading causes of death (cancers, cardiovascular diseases, cerebrovascular diseases, diseases of 
the respiratory system and injury, poisoning & external causes) in China. The major risk factors 
causing cancers are tobacco consumption, chronic infections, diet and lack of physical activity, 
etc.26 Cancer is a leading cause of death globally, accounting for 7.6 million deaths in 2008.27 
Nearly 70% of cancer deaths occurred in low- and middle-income countries. It is predicted that 
deaths from cancer will increase, with an estimated 13.1 million deaths in 2030.28 Cancer is a 
big problem for society worldwide as well as for China. With the gradual increase in the 
number of patients and mortality, the demand for diagnosis and treatment devices will 
inevitably increase. Good market prospects indicate that medical devices for these diseases 
have great investment potential. 
Discussion 
This study suggests that the Chinese medical device market is not only driven by the three 
variables (number of hospital visits, 65+ population and number of hospitals) but is also 
impacted by the diseases and the government healthcare policy. The purpose of medical 
devices is to assist with: patient stratification, diagnosis, prognosis, treatment and treatment 
planning; the macroeconomic variables such as population structure; disease profiles and 
economic level can affect the demand for medical device services. Disease profiles affect the 
development of medicine as well as medical device capabilities and the total medical device 
market. Therefore, diseases should be one of the elements driving medical device investment.  
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If the incidence or mortality from the disease is low, the demand and frequency of use of the 
appropriate diagnosis and treatment equipment will be relatively low, the investment payback 
period for such medical devices will be long for hospitals; in such a scenario, it is difficult for 
hospitals to recover the cost of medical devices throughout their entire life cycle. So only the 
large general hospitals will consider purchasing such medical devices. Small and medium-sized 
hospitals do not have the capacity to buy such equipment. Thus, the market demand for medical 
devices with low disease incidence is relatively small; investment risk is large and does not 
have financial investment value. If the incidence or mortality of the disease is high, the demand 
and frequency of use of the appropriate diagnosis and treatment equipment will be relatively 
high, the large general hospitals will be very motivated to purchase such medical devices as 
well as small and medium-sized hospitals because the investment payback period for such 
devices will be short. 
The medical device market has sustainable growth because of the general demographic trends, 
especially the growth of the aging population and the continued prevalence of diseases.29 For 
the Chinese medical device market, the growth of hospital visits, aging population, number of 
hospital and diseases show that the market has great investment opportunities. The main 
medical devices companies’ (such as GE, Philips and Siemens) investment activities and/or 
mergers and acquisitions in China give good indicators of how the market is developing.   
The limitation of this study is that appropriate explanatory variables are hard to find, three 
explanatory variables made the sample size too small to perform regression analysis. Other 
market drivers like disease and policy are hard to assess through regression analysis. The 
multicollinearity often happens in multiple regression analysis, the adjusted results reported 
herein are more reliable.  
Conclusion 
According to the regression analysis, the number of hospital visits, 65+ population and number 
of hospitals are the main drivers of the Chinese medical device market. Diseases are another 
driving force. Analysis of the prevalence of diseases shows that cancers are the big challenge 
for the whole medical area, the health care system is experiencing huge pressures from both 
changing and increasing demands.30 Therefore, significant opportunities exist in the Chinese 
medical device market due to the growth of the number of hospital visits, 65+ population, 
number of hospitals and diseases. 
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